Overall, the prevalence of GATA2 mutations reach 72% in adolescent (age 12–19) with MDS associated with monosomy 7, while its prevalence is 16% in patients with MDS and trisomy 8. This evidence concerns the gene GATA2 and myelodysplastic syndrome.